One recent study has established that individuals who consume oral bisphosphonates for osteoporosis or the bone disease for more than five years might increase the risk of developing esophageal cancer by almost two times.
Oral bisphosphonates is a kind of drug that is used as treatment for osteoporosis and various other bone diseases.
A data obtained from the UK General Practice Research Database was analysed by researchers from the University of Oxford’s Cancer Epidemiology Unit and the Medicines and Healthcare products Regulatory Agency.
The finding made by them concluded as having found that people using drugs for five or more years increased their chances of developing esophageal cancer by two times in comparison to those who did not take the drugs.
Jane Green of Oxford University Epidemiology Unit said that this was the biggest ever study that has been conducted that has been able to find the drug effect and there are ever increased concerns regarding the same.
She said that since esophageal cancer is not so commonly seen, but the double risk was not such a gigantic risk to be perceived.
Bisphosphonates are those drugs that belong to the category of drugs helping in bone fractures and also counteract frailties related to menopause and osteoporosis.
- Gentle Electrical Stimulation May Help in Improving Maths Skills
- Mutated BRCA1 Gene Increases Breast Cancer Risk
- Research Finds Huge Increase in Type-2 Diabetes, Under-40 Hardest Hit
- Step Forward in IVF Treatment in 30 Can Mount up Baby Production Three-times
- David Cameron Blamed for ‘Scaremongering’ Over Health Tourism